Crossmark

Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes

Crossref DOI link: https://doi.org/10.1016/j.gastre.2025.502472

Published Print: 2025-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Iniesta-Navalón, Carles

Rentero-Redondo, Lorena

Gómez-Espín, Rosa

Ríos Saorín, Manuel

Nicolás de Prado, Isabel

Gascón-Cánovas, Juan José
License Information

Text and Data Mining valid from 2025-12-01

Text and Data Mining valid from 2025-12-01

stm-asf valid from 2025-12-01

stm-asf valid from 2025-12-01

stm-asf valid from 2025-12-01

stm-asf valid from 2025-12-01

stm-asf valid from 2025-12-01
More Information

This article is maintained by: Elsevier

Article Title: Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2025.502472

Content Type: article

Copyright: © 2025 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.